HEPATITIS B, CHRONIC
Clinical trials for HEPATITIS B, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental hepatitis b drug shows promise but study halted early
Disease control TerminatedThis study tested a new drug called ARC-520, given with the standard medicine entecavir, to see if it could lower hepatitis B virus levels in people with chronic infection. The trial included 58 adults with different types of chronic hepatitis B. The study was stopped early, so r…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New vaccine aims to control hepatitis b without lifelong drugs
Disease control TerminatedThis study tested a treatment called HepTcell, which is like a vaccine that trains the immune system to fight the hepatitis B virus. It was for people with inactive chronic hepatitis B who had not taken any antiviral drugs before. The goal was to see if it could lower virus level…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated May 26, 2026 10:29 UTC
-
New vaccine aims to control hepatitis b in patients on standard treatment
Disease control TerminatedThis study tested a new therapeutic vaccine (GSK3528869A) in adults aged 18-65 with chronic hepatitis B whose virus was already well-controlled by standard antiviral pills. The goal was to see if the vaccine could further reduce virus levels and improve the immune response. The t…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 18, 2026 12:00 UTC